Document is current
Any future updates will be listed below
-
Authors
Han, Ru https://orcid.org/0000-0002-4851-1462
San Martin, Peter https://orcid.org/0000-0002-6987-7850
Ahmed, Nurilign https://orcid.org/0000-0003-3953-7473
Guzman-Holst, Adriana https://orcid.org/0000-0002-6753-2541
Mohy, Ahmed https://orcid.org/0000-0002-4605-8254
Pinto, Thatiana https://orcid.org/0000-0002-0957-3118
de Veras, Bruna https://orcid.org/0000-0002-7927-050X
Gomez, Jorge A. https://orcid.org/0000-0001-5459-4973
Bibera, Gyneth Lourdes https://orcid.org/0000-0001-8512-6857
van Oorschot, Désirée A. M. https://orcid.org/0000-0002-0382-0333
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 15 February 2024
First Online: 17 March 2024
Declarations
:
: Ru Han, Peter San Martin, Thatiana Pinto, Bruna de Veras, Gyneth Lourdes Bibera: Employees of GSK; Nurlign Ahmed, Adriana Guzman-Holst, Ahmed Mohy, Jorge A. Gomez, Désirée A. M. van Oorschot: Employees and shareholders of GSK.
: This model is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
